Hemophagocytic lymphohistiocytosis (HLH) in 2025 Dengue outbreak in Chittagong, Bangladesh

This observational study conducted in Chittagong, Bangladesh, during the 2025 dengue outbreak describes the clinical presentation, laboratory findings, and favorable outcomes of 14 patients diagnosed with dengue-induced hemophagocytic lymphohistiocytosis (HLH), highlighting the condition's association with specific serotype patterns and the importance of early detection.

The Gist

Imagine your body is a bustling, well-organized city. Normally, the immune system acts like the city's police force and fire department, working together to fight off invaders (like viruses) and keep things running smoothly.

The Story of the 2025 Chittagong Outbreak

In the second half of 2025, the city of Chittagong, Bangladesh, faced a familiar enemy: the Dengue virus. Usually, when the police (immune system) spot a burglar (the virus), they send a few officers to handle it, and the neighborhood returns to normal.

However, in this specific study, researchers noticed something scary happening in 14 unlucky residents. Instead of a controlled police response, the immune system went into a state of total panic. This condition is called Hemophagocytic Lymphohistiocytosis (HLH).

The "Friendly Fire" Analogy

Think of HLH as a case of massive friendly fire. The immune system gets so confused and over-activated by the Dengue virus that it stops distinguishing between the enemy and its own citizens. It starts attacking the body's own organs and blood cells, essentially burning down its own city to stop the virus. If not caught early, this "civil war" inside the body can be fatal.

Who Got Sick?

The study looked at 14 people who developed this dangerous reaction.

• The Crowd: Most of them were men (about 8 out of 10), and they were mostly adults between 20 and 50 years old.
• The Symptoms: It wasn't just a bad flu. Everyone had a fever lasting more than a week. Many had severe headaches, vomiting, and rashes (like a red warning sign on the skin). Some had bleeding issues, while others had pain in their eyes or belly.
• The Clues: When doctors checked their blood, they found a chaotic mix of signals:
  • Low numbers: The body was running out of red blood cells, white blood cells, and platelets (like a city running out of fuel, police, and construction workers).
  • High alarms: A protein called ferritin was skyrocketing (like a smoke alarm going off at maximum volume), and the liver enzymes were high, showing the organs were under stress.

The Mystery of the Virus

The researchers also played detective with the virus itself. They found that in many cases, the patients had been exposed to Dengue more than once.

• Some had the virus for the first time (IgM positive).
• Some had it before and were getting hit again (IgG positive).
• Some had both.

This suggests that maybe the "villain" changed its disguise (different serotypes), or the body's memory of the virus confused the immune system, triggering this panic attack.

The Outcome: A Narrow Escape

The good news is that because the doctors in Chittagong were watching closely, they caught the problem early.

• 12 out of 14 patients were treated successfully and went home healthy.
• 2 patients got very sick and needed the Intensive Care Unit (ICU). One survived, but sadly, one did not make it.

The Big Takeaway

The main lesson from this paper is that while Dengue has been around for a long time, it is evolving. It can sometimes trigger this rare, dangerous "immune system meltdown" (HLH).

The researchers are now wondering: Is this happening because the virus is changing its costume, or because people are getting infected with different versions of the virus at the same time? They believe this is a new mystery that scientists need to solve to save more lives in the future.

In short: Dengue is the burglar, but HLH is the immune system accidentally setting the house on fire. The doctors in Chittagong learned how to put out that fire quickly, but they need to figure out exactly why the fire started in the first place.

Technical Summary

Technical Summary: Hemophagocytic lymphohistiocytosis (HLH) in the 2025 Dengue Outbreak in Chittagong, Bangladesh

1. Problem Statement

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that can be triggered by viral infections, including Dengue. While Dengue is endemic in Bangladesh, the emergence of HLH as a severe complication represents a critical clinical challenge. Early detection and appropriate management are vital, as untreated HLH carries a high mortality rate. The study addresses the gap in understanding the specific clinical presentation, diagnostic patterns, and outcomes of Dengue-induced HLH within the context of the 2025 outbreak in Chittagong.

2. Methodology

• Study Design: An observational study conducted over a six-month period from July 1, 2025, to December 31, 2025.
• Setting: A medical college hospital in Chittagong, Bangladesh.
• Participants: 14 patients admitted and diagnosed with HLH secondary to Dengue virus infection.
• Inclusion Criteria: Patients meeting established diagnostic criteria for HLH who provided informed written consent.
• Data Collection & Analysis: Data were collected prospectively and followed up until discharge. Analysis was performed using Microsoft Excel 2010.
• Ethical Considerations: The study received clearance from the institution's Ethical Review Board.

3. Key Contributions

• Clinical Characterization: The study provides a detailed profile of the clinical and laboratory manifestations of Dengue-induced HLH in a Bangladeshi cohort, highlighting specific symptom frequencies and demographic trends.
• Diagnostic Correlation: It correlates HLH diagnosis with specific Dengue serological and molecular markers (RT-PCR, IgM, and IgG), offering insights into the timing of infection (primary vs. secondary) relative to HLH onset.
• Outcome Analysis: The research documents the mortality and morbidity rates associated with this specific complication, emphasizing the necessity of intensive care intervention in severe cases.

4. Key Results

• Demographics:
  • Gender: Male predominance was observed (78.6% male vs. 21.4% female).
  • Age: The majority of patients fell within the 20–50 years age group.
• Clinical Presentation:
  • Universal Symptom: All 14 patients (100%) presented with fever lasting more than 7 days.
  • Common Symptoms: Headache (78.6%), vomiting (78.6%), skin rashes (71.4%), bleeding manifestations (71.4%), loose motion (64.3%), and splenomegaly (64.3%).
  • Less Common Symptoms: Abdominal pain (50%), cough (28.6%), jaundice (28.6%), joint pain (21.4%), and retro-orbital pain (14.3%).
  • Comorbidities: Only one patient (7.1%) had a history of hypertension.
• Laboratory Findings:
  • Hematology: Evidence of bicytopenia or pancytopenia.
  • Biochemistry: Elevated ferritin and triglycerides (TG); low fibrinogen; elevated liver enzymes; and hyponatremia (low sodium).
• Dengue Serology & Molecular Testing:
  • Dual Positive: 8 cases (57.1% of the total, though the abstract notes 42.9% for this specific group, likely a calculation discrepancy in the source text; strictly following the count: 8/14) were positive for both IgM and IgG.
  • RT-PCR Positive: 6 cases.
  • IgM Only: 2 cases.
  • IgG Only: 4 cases.
  • Note: The distribution suggests a mix of primary and secondary infections, with a significant portion showing evidence of recent or past exposure.
• Outcomes:
  • Recovery: 12 patients (85.8%) improved and were discharged without complications.
  • Critical Care: 2 patients required ICU transfer.
  • Mortality: 1 patient died (7.1% overall mortality; 50% mortality among ICU transfers). 1 ICU patient survived.

5. Significance and Conclusion

The study underscores that HLH is an evolving and potentially fatal complication of Dengue fever in the region. The authors hypothesize that the pathogenesis may be linked to infection by different Dengue serotypes at different times or co-infection with multiple serotypes. This research highlights the need for clinicians to maintain a high index of suspicion for HLH in Dengue patients presenting with prolonged fever, cytopenias, and hyperferritinemia. The findings suggest that while the majority of cases can be managed with standard care, early identification is crucial to prevent the progression to critical illness and death. Future research is recommended to explore the specific immunological mechanisms and serotype interactions driving HLH in Dengue-endemic areas.